AI and semiconductor stocks are overvalued and shifting to healthcare stocks like Eli Lilly and Company could be wise. Click ...

Introduction Burden of non-communicable diseases (NCDs) continues to rise in low- and middle-income countries like Kenya. People with HIV (PWH) may be at greater risk for obesity and NCDs. National ...

Type 2 diabetes and obesity are interconnected health concerns, often creating a cycle of declining well-being. Addressing ...

License agreement supports Madrigal's pipeline strategy to develop innovative combination treatments for MASH, anchored by its foundational therapy Rezdiffra (resmetirom) Combining Rezdiffra with the ...

The antibody discovery market is expanding, driven by the increasing incidence of chronic conditions such as cancer, diabetes, and cardiovascular and neurological diseases. The adoption of biologics, ...

The collapse followed Novo's downward revision of its 2025 outlook, citing weaker-than-expected international uptake .

Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion as the Company prepares to launch U.S. Phase 2a by year-end MIAMI, FLORIDA / ...

People are buying weight loss drugs online but the cut-price deals may not be what they seem to be, health chiefs warned.

Abbott Laboratories (NYSE:ABT) ranks among the best low volatility stocks to buy according to analysts. RBC Capital ...

In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?